Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valganciclovir Prophylaxis vs Preemptive Therapy in Liver Transplant
NCT01552369Phase 4Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Oct 2012
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valganciclovir in cytomegalovirus infection (CMV), sponsored by National Institute of Allergy and Infectious Diseases. Started Oct 2012; status: completed.
02
Drugs
valganciclovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT01552369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01552369.